Ethyl 2-bromo-4-(difluoromethyl)oxazole-5-carboxylate, 500mg

2-Fluoro-3-methylpyridine, 97.0%, 10g

6-Bromo-2-methyl-2H-indazole, 97.0%, 25g

2-methyl-2-(morpholin-4-yl)propanoic acid hydrochloride, 1g

METHYL 3-ETHYNYL-4-METHYLBENZATE, 97.0%, 1g

6-aminohexanoic acid, min. 99%, for synthesis, 100 g, plastic packaging.

(4S,4'S)-1,1'-Bis(3-(tert-butyl)phenyl)-4,4'-diisobutyl-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 1g

2-BROMOMETHYL-5,8-DIOXASPIRO[3.4]OCTANE, 95.0%, 250mg

1-(Phenanthren-9-yl)ethan-1-one, 10g

Ethyl 3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)acrylate, 95.0%, 5g

2-(2-Hydroxyethoxy)ethyl 4-methylbenzenesulfonate, 98.0%, 1g

(R)-Octahydropyrazino[2,1-c][1,4]oxazine dihydrochloride, 95.0%, 1g

1-(2-Methoxyphenyl)ethanol, 98.0%, 5g